Oncolytics Biotech announces pricing of its public offering of common share and warrants
Oncolytics Biotech® announced pricing of its previously announced underwritten public offering of 4,619,773 common shares and warrants to purchase up to 4,619,773 common shares at a combined public offering price of $0.81 per share and warrant, resulting in gross proceeds of $3.7 million. August 14, 2019